Related Experiment Video
Updated: Nov 23, 2025

12:43
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
Published on: February 21, 2011
35.5K
Poor Bone Quality in Patients With Amyotrophic Lateral Sclerosis
Jordi Caplliure-Llopis1,2, Dolores Escrivá3, María Benlloch4
1School of Doctorate, Valencia Catholic University, Valencia, Spain.
Frontiers in Neurology
|January 4, 2021
Summary
Amyotrophic lateral sclerosis (ALS) patients, especially females, have significantly poorer bone quality and higher fracture risk compared to healthy individuals. Bone health in ALS is linked to Vitamin D and TSH levels, not clinical status.
Area of Science:
- Orthopedics
- Neurology
- Endocrinology
Background:
- Amyotrophic lateral sclerosis (ALS) is linked to increased bone fractures due to musculoskeletal deterioration.
- Understanding bone quality in ALS patients is crucial for managing associated health risks.
- Investigating the influence of sex and ALS type on bone health is important.
Purpose of the Study:
- To compare bone quality between ALS patients and healthy controls.
- To evaluate the impact of sex and ALS type on bone health in ALS.
- To analyze the relationship between clinical status, metabolic parameters, and bone health in ALS patients.
Main Methods:
- Quantitative ultrasound (QUS) of the calcaneus was used to assess bone mass quality in 33 ALS patients and 66 healthy controls.
- Measurements included ultrasonic broadband attenuation (BUA), speed of sound (SOS), stiffness index, and T-score.
- Clinical data (ALSFRS-R, Barthel index, FVC, MRC scale) and metabolic parameters (Vitamin D, TSH, calcium, ALP) were analyzed.
Main Results:
- ALS patients exhibited significantly lower bone parameters (BUA, SOS, stiffness, T-score) than healthy controls.
- ALS females showed poorer bone parameters compared to healthy females; 75.8% of ALS patients had an osteoporotic profile.
- Vitamin D and TSH levels positively correlated with bone parameters, while clinical status showed no correlation.
Conclusions:
- ALS patients, particularly females, demonstrate significantly deteriorated bone health compared to healthy individuals.
- Structural bone changes in ALS are independent of ALS subtype and clinical status.
- Bone health in ALS appears to be associated with metabolic factors, specifically Vitamin D and TSH levels.
Related Concept Videos
Bone Disorders
4.9K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.9K
Cross-bridge Cycle
121.0K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
121.0K
Amyloid Fibrils
11.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.2K
What is the Skeletal System?
55.5K
Overview
55.5K
Disorders of the Skeletal Muscle
1.5K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.5K
Parkinson's Disease: Overview
1.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.2K

